Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs HeliMeds

By GLP-1 ScorecardUpdated

EffectyFactor scores not reassessed.
Site position #21

Higher score

HeliMedsFactor scores not reassessed.
Site position #163

Lower score

Score comparison

Effecty has the higher recorded score — 83.7/100 to 68.3/100.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Separate compounded/branded offers; confirm discounts, billing and exit terms.

Before you choose

Before comparing the headline prices, the Effecty review and the HeliMeds review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Effecty vs JM Integrated Health and Gala Health vs HeliMeds compare each of them with another graded program, and the list of alternatives to Effecty ranks the programs closest to Effecty on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEffecty +6
80
74
Dose & formulationEffecty +7
84
77
Clinical oversightEffecty +14
85
71
Labs & monitoringEffecty +32
84
52
FulfillmentEffecty +20
87
67
Contract termsEffecty +31
86
55
Effecty · top barHeliMeds · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEffectyHeliMeds
WeighScore83.7/10068.3/100
GradeBC
Site position#21#163
Semaglutide$170/month before code; advertised $95 first month. Supply unconfirmed.$225 per 4 weeks (advertised compounded refill; confirm selected plan)
Tirzepatide$235/month before code; advertised $160 first month. Supply unconfirmed.$285 per 4 weeks (advertised compounded refill; confirm selected plan)
CoverageNationwide shipping claimed; confirm treatment-specific eligibility.38 states advertised for compounded care; confirm eligibility
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Effecty

Site position #21 · B

Factor scores not reassessed.

Strengths

  • Medication-specific billing terms
  • Dose-independent pricing advertised
  • Separate Wegovy offer published

What to consider

  • Selected total/supply unconfirmed
  • Prescription sales described as final
  • Assigned pharmacy and individual credentials unverified
HeliMeds

Site position #163 · C

Factor scores not reassessed.

Strengths

  • Product pages identify four- and twelve-week refill amounts
  • The public catalog lists Wegovy and Zepbound separately from compounded options

What to consider

  • The pages show multiple introductory prices, so the selected first charge is unresolved
  • Cancel-anytime wording does not establish a refund on a prepaid supply
  • Confirm eligibility and the individual dispensing pharmacy before ordering

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard